Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/5535
Email LibraryRMU.DOH@nt.gov.au to ask for this document in a different format
Title: Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis.
Authors: Commons, R J
Grivas, R
Currie, B J
Citation: Internal medicine journal 2014-12; 44(12a): 1245-6
Abstract: Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei and can present with severe sepsis. Predisposing risk factors are present in 80% of cases. Monoclonal antibodies are increasingly prescribed for varied medical conditions. This report describes the first known case of melioidosis in a patient whose only risk factor for disease is treatment with a monoclonal antibody. Prescribers of monoclonal antibodies and other immunosuppressants should ensure that their patients are aware of the potential risk of melioidosis prior to travel and the precautions that should be taken.
Click to open PubMed article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/25442759
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/25442759
Journal title: Internal medicine journal
Publication Date: 2014-12
Type: Case Reports
Journal Article
Research Support, Non-U.S. Gov't
URI: https://hdl.handle.net/10137/5535
DOI: 10.1111/imj.12610
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.